Skip links

GSS EU Science Funding Gateway

Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

HORIZON-MISS-2027-02-CANCER-04
Forthcoming
General information
ProgrammeHorizon Europe (HORIZON)
Programme divisionHorizon Europe Framework Programme (HORIZON); Global Challenges and European Industrial Competitiveness; Health
CallHORIZON-MISS-2027-02 (Supporting the implementation of the Cancer Mission)
Type of actionHORIZON-RIA HORIZON Research and Innovation Actions
Type of MGAHORIZON Lump Sum Grant
Deadline modelsingle-stage
Planned opening date10 February 2027
Deadline date16 September 2027
StatusForthcoming
OECD fieldsClinical medicine, Economics and Business, Health sciences
EC cross-cutting prioritiesDigital Agenda, Artificial Intelligence
Cluster or programme partEU Missions (HORIZON-MISS)
Thematic communities (as in the COST Action Graph)Cancer
Beneficiary categories (GSS model, in training)Legal Entities
Topic description

Expected Outcome:

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:

  • People at risk of cancer, cancer patients and their caregivers/families benefit from access to more effective and cost-effective, national or regional, cancer control programmes across EU Member States and Associated Countries.
  • Researchers, physicians, innovators[1], SMEs and other professionals from different disciplines and sectors have access to national, regional or local data on healthcare spending (such as expenditures, resource allocations, organisation and type of healthcare interventions, and for which cancer indications, infrastructure, medical prescriptions, drug pricing, drug sales, reimbursement data from health insurers, population-based cancer registries or other cancer-centred registry data, longitudinal epidemiology data) for research and commercial purposes.
  • National or regional healthcare systems, healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to improve equitable health outcomes of cancer patients by addressing direct and indirect costs, delivering value-driven cancer care and tackling organisational challenges of a rapidly-changing, dynamic cancer control[2] landscape.

Scope:

Proposals should address all of the following:

  • Establish, validate or further refine health-economics research, health systems research, epidemiological or outcomes research methods, models, or modelling to perform (comparative) cost-effectiveness and epidemiological analyses benefiting equitable health outcomes of and added value for people at risk of cancer as well as cancer patients living with and beyond their disease.
  • Take into account socio-economic inequalities, socio-demographic, organisational, innovative or cultural trends, socio-cultural or behavioural change (for example in the case of primary prevention or precision medicine) by involving people at risk of cancer or cancer patients and their caregivers/families through research that stimulates social innovation and supports end-user engagement using participative research models.
  • Calculate cancer-control related healthcare expenditures[3] and its relation to value-driven healthcare benefitting health outcomes of people at risk of cancer as well as cancer patients living with and beyond their disease, taking into account the needs of the target population and the specificities of healthcare provision at local, regional, or national level, duly reflecting the (cultural) diversity and available resources across EU Member States and Associated Countries.
  • Improve health outcomes of people at risk of cancer or cancer patients and their caregivers/families living with and beyond their disease, by demonstrating how to improve access to and the organisation of state-of-the-art, evidence-based, cost-effective cancer control programmes in dedicated cancer centres or medical centres, hospitals, at home or in community settings, taking into account the socio-cultural context, harms and benefits, overall survival or quality of life parameters.

The successful proposals are expected to build on resources made available by the Knowledge Centre on Cancer (KCC) to foster EU alignment and coordination[4].

Successful proposals will be asked to join the 'Understanding' project cluster of the EU Cancer Mission[5] and should include a budget for networking, attendance at meetings and joint activities[6]. The Commission will facilitate coordination of these activities.

[1] Innovators turn research results into new and better services and products, to remain competitive in a global marketplace and to improve the quality of life of Europe’s citizens

[2] cancer control aims to reduce the incidence, morbidity and mortality of cancer and to improve the quality of life of cancer patients in a defined population, through the systematic implementation of evidence-based interventions for prevention, early detection, diagnosis, treatment, and palliative care

[3] Healthcare expenditure statistics - overview - Statistics Explained - Eurostat

[4] Hosted by the European Commission's Joint Research Centre (JRC). Especially through the ’European Guidelines and Quality Assurance Schemes for Breast, Colorectal and Cervical Cancer Screening and Diagnosis‘, and the ’European Cancer Information System (ECIS)’ and the ’European Cancer Inequalities Registry (ECIR), see https://knowledge4policy.ec.europa.eu/cancer_en.

[5] To address the objectives of the EU Cancer Mission, participants will collaborate in project clusters to leverage EU-funding, increase networking across sectors and disciplines, and establish a portfolio of EU Cancer Mission R&I and policy actions.

[6] Examples of those activities are organising joint workshops, establishing best practices, joint communication or citizen engagement activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate. Proposals are not required to include details of these activities, as they will be defined during the grant agreement preparation and during the life of the project.

Topic conditions and documents
">

General conditions

1. Admissibility conditions: Proposal page limit and layout

described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries

described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligibility Conditions

described in Annex B of the Work Programme General Annexes.

4. Financial and operational capacity and exclusion

described in Annex C of the Work Programme General Annexes.

5a. Evaluation and award: Award criteria, scoring and thresholds

described in Annex D of the Work Programme General Annexes.

5b. Evaluation and award: Submission and evaluation processes

The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12.

described in Annex F of the Work Programme General Annexes and the Online Manual.

5c. Evaluation and award: Indicative timeline for evaluation and grant agreement

described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants

Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].

The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.

described in Annex G of the Work Programme General Annexes.

Specific conditions

described in the specific topic of the Work Programme

Budget overview
Topic and type of actionBudget 2027 (EUR)StagesOpening dateDeadlineContributions (EUR)Indicative number of grants
HORIZON-MISS-2027-02-CANCER-03 - HORIZON-RIA HORIZON Research and Innovation Actions24 000 000single-stage10 February 202716 September 20277 000 000 to 9 000 0003
HORIZON-MISS-2027-02-CANCER-02 - HORIZON-IA HORIZON Innovation Actions20 000 000single-stage10 February 202716 September 20277 000 000 to 10 000 0003
HORIZON-MISS-2027-02-CANCER-06 - HORIZON-CSA HORIZON Coordination and Support Actions3 000 000single-stage10 February 202716 September 20273 000 0001
HORIZON-MISS-2027-02-CANCER-01 - HORIZON-RIA HORIZON Research and Innovation Actions32 323 812single-stage10 February 202716 September 20277 000 000 to 8 000 0004
HORIZON-MISS-2027-02-CANCER-05 - HORIZON-PCP HORIZON Pre-commercial Procurement26 000 000single-stage10 February 202716 September 20278 000 000 to 10 000 0003
HORIZON-MISS-2027-02-CANCER-04 - HORIZON-RIA HORIZON Research and Innovation Actions10 000 000single-stage10 February 202716 September 20275 000 000 to 7 000 0003
Partner search
On the EU Funding & Tenders portal

The portal lists the partner search announcements published for this topic: open the topic on the portal and go to "Partner search announcements".

Through the GSS community

No requests yet for this call.

Post a partner request for this call

Topic Q&As

Questions and answers published by the EC for this topic are on the portal: open the topic on the portal and go to "Topic Q&As".

Get support

Online Manual is your guide on the procedures from proposal submission to managing your grant.

Horizon Europe Programme Guide contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.

Funding & Tenders Portal FAQ – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.

Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

National Contact Points (NCPs) – get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (‘third-countries’).

Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk – contact the Funding & Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

European IPR Helpdesk assists you on intellectual property issues.

CEN-CENELEC Research Helpdesk and ETSI Research Helpdesk – the European Standards Organisations advise you how to tackle standardisation in your project proposal.

The European Charter for Researchers and the Code of Conduct for their recruitment – consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.

Partner Search help you find a partner organisation for your proposal.

Keywords

Keywords

ElderlyHealth inequalitiesPhysical activity/ExercisePublic healthQuality of health careQuality-of-lifeRehabilitation
Source

Content published by the European Commission on the EU Funding & Tenders portal, updated automatically.

This website uses cookies to improve your web experience.
Home
Account
Cart
Search
Explore
Drag